The cost-effectiveness of high dose oral versus intravenous proton pump inhibition in high-risk patients with bleeding peptic ulcers having undergone therapeutic endoscopy

被引:0
|
作者
Barkun, A
Adam, V
Kennedy, WA
Fallone, CA
Herba, K
Bardou, K
机构
[1] McGill Univ, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[2] Univ Montreal, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1016/S1098-3015(10)63972-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:248 / 248
页数:1
相关论文
共 50 条
  • [31] Embolization as Treatment of Choice for Bleeding Peptic Ulcers in High-Risk Patients
    van Vugt, Raoul
    Bosscha, Koop
    van Munster, Ivo P.
    de Jager, Cornelis P. C.
    Rutten, Matthieu J. C. M.
    [J]. DIGESTIVE SURGERY, 2009, 26 (01) : 37 - 42
  • [32] Predictors of Rebleeding and Mortality in Patients with High-Risk Bleeding Peptic Ulcers
    Cheng, Chi-Liang
    Lin, Cheng-Hui
    Kuo, Chia-Jung
    Sung, Kai-Feng
    Lee, Ching-Song
    Liu, Nai-Jen
    Tang, Jui-Hsiang
    Cheng, Hao-Tsai
    Chu, Yin-Yi
    Tsou, Yung-Kuan
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (09) : 2577 - 2583
  • [33] Predictors of Rebleeding and Mortality in Patients with High-Risk Bleeding Peptic Ulcers
    Chi-Liang Cheng
    Cheng-Hui Lin
    Chia-Jung Kuo
    Kai-Feng Sung
    Ching-Song Lee
    Nai-Jen Liu
    Jui-Hsiang Tang
    Hao-Tsai Cheng
    Yin-Yi Chu
    Yung-Kuan Tsou
    [J]. Digestive Diseases and Sciences, 2010, 55 : 2577 - 2583
  • [34] DIAGNOSTIC STRATEGIES FOR HELICOBACTER PYLORI IN PATIENTS WITH BLEEDING PEPTIC ULCERS UNDERGOING ENDOSCOPY: A COST-EFFECTIVENESS ANALYSIS
    Artin, Michael G.
    Ingram, Myles A.
    Lim, Francesca
    Nathanson, John T.
    Hur, Chin
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S678 - S678
  • [35] Intravenous proton pump inhibitor (IV PPI) prior to endoscopy "downstage" high-risk lesions in patients with bleeding peptic ulcer (PUD): A multicenter comparative study
    Andrews, C
    Levy, A
    Fishman, M
    Hahn, M
    Atkinson, K
    Kwan, P
    Enns, R
    [J]. GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB149 - AB149
  • [36] A comparison of intravenous (IV) versus oral proton pump inhibitors (PPIs) for patients with high-risk acute nonvariceal upper GI bleeding (ANVUGIB)
    Targownik, Laura E.
    Keyvani, Leila
    Murthy, Sanjay K.
    Leeson, Shanua
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A464 - A464
  • [37] Retrospective Comparison of Oral vs. Intravenous Proton-Pump Inhibitor Therapy in Patients with Acute Peptic Ulcer Bleeding and High-Risk Endoscopic Stigmata
    Henry, Michael J.
    Puchakayala, Bharat K.
    Raghavendra, Meghana
    Mathiason, Michelle A.
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A608 - A608
  • [38] The cost-effectiveness of IV versus PO proton pump inhibitor (PPI) therapy in the management of high-risk ulcer hemorrhage
    Spiegel, B
    Lim, B
    Dulai, GS
    Mann, N
    Kanwal, F
    Gralnek, IM
    [J]. GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) : AB156 - AB156
  • [39] The prediction of recurrent bleeding leading to surgery or death after therapeutic endoscopy and adjunctive use of intravenous high dose omeprazole infusion for bleeding peptic ulcers
    Chiu, PWY
    Lau, JY
    Ng, EK
    Chan, FK
    Sic, P
    Sung, JJ
    [J]. GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) : AB90 - AB90
  • [40] Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers A retrospective observational cohort study
    Hsieh, Hui-Hsia
    Wu, Tien-Yuan
    Chen, Chi-Hua
    Hour, Mann-Jen
    [J]. MEDICINE, 2021, 100 (49)